FIBROGEN INC — Director's Dealing 2015

Dec 1, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-11-25

Reporting Person: Yu K Peony (VP, Clinical Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-25	Common Stock	S	344	$30.00	Disposed	183001	Direct
2015-11-30	Common Stock	S	4656	$30.00	Disposed	178345	Direct

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.